medigraphic.com
ISSN 2448-8011 (Electronic)
Revista de Divulgación del INSTITUTO DE MEDICINA FORENSE de la UNIVERSIDAD VERACRUZANA

2018, Number 1

<< Back

Rev Mex Med Forense 2018; 3 (1)

Prevalence of tuberculosis mortality in the mexican state of Veracruz during 2010-2017: a review

Infanzón-Ruiz R, Melo-Santiesteban G, Aguirre-Del Barrio MF, Siliceo-Benitez J

Language: Spanish
References: 17
Page: 68-74
PDF size: 480.01 Kb.


ABSTRACT

Pulmonary tuberculosis is a global health problem, especially in the Asian continent; in America, Mexico is one of the countries with the highest prevalence; the state of Veracruz, according to statistics published in 2017, is the state of the republic with the highest number of new cases of pulmonary tuberculosis per year and the second state with the highest number of deaths due to pulmonary tuberculosis per year; it is evident that these estimates ensure the need to carry out epidemiological studies to determine the sociodemographic and health factors that could determine the high prevalence;in the same way, it is necessary to take into account this information for the realization of awareness campaigns and the development of preventive models that reduce the prevalence of pulmonary tuberculosis in the state of Veracruz.


REFERENCES

  1. Daniel TM (2000). The origins and precolonial epidemiology of tuberculosis in the Americas: can we figure them out? Int J Tuberc Lung Dis; 4:395-400.

  2. Cardona PJ, Ruiz-Manzano J (2004). On the nature of Mycobacterium tuberculosis-latent bacilli. Eur Respir J, 24:1044-1051

  3. World Health Organization (2004). Global tuberculosis control: Surveillance, planning, financing. Genova.

  4. Bloom BR, Murray CJ (2002). Tuberculosis: commentary on a reemergent killer. Science; 257:1055–1064.

  5. Wolinsky E (1990). Mycobacterium. Tratado de microbiología. 3ra ed. México: Salvat.

  6. Schnappinger D, Ehrt S (2016). A broader spectrum of tuberculosis. Nature Medicine, 22: 1076-1077.

  7. Fitzgerald D, Sterling T, Haas D (2002). Mandell´s Principles and Practice of Infectious Diseases. Ed Saunders, Estados Unidos.

  8. GTR (2015). Global Tuberculosis Report 2015. World Health Organization.

  9. Lineamientos para la Vigilancia Epidemiológica de la Tuberculosis por Laboratorio (2014). Dirección General de Epidemiología, Secretaría de Salud, Instituto de Diagnóstico y referencia Epidemiológicos “Dr. Manuel Martínez Báez”, México.

  10. Angulo G, López L, Ramírez F (2014). Experiencia de un laboratorio de tercer nivel de atención en el diagnóstico de infecciones por micobacterias. Rev Latinoam Patol Clin Med Lab; 61 (3): 156-162.

  11. Flores S, Mendoza S, Garza E (2014). Drug resistance and molecular epidemiology of Mycobacterium tuberculosis in Mexico: a systematic review. Salud Publica Mex; 56(1):63-77.

  12. Delgado J, Perez AI, Perez P (2014). Guía de atención rápida en clínicas médicas: Tuberculosis Pulmonar. Editorial Elsevier, España.

  13. Global Tuberculosis Report 2014. World Health Organization.

  14. Informe de la Reunión Regional de Jefes de Programas Nacionales de Control de la Tuberculosis (2012). Organización Panamericana de la Salud (0PS). Programa Regional de Tuberculosis. San Paulo, Brasil.

  15. Cowman S, Wilson R, Loebinger MR (2012). Opportunistic mycobacterial diseases. J Infect Dis, 40(6): 346-348.

  16. Lawn SD, Zumla AI (2011). Tuberculosis. The Lancet; 378(9785):57-72

  17. Manual de Procedimientos Estandarizados para la Vigilancia Epidemiológica de las Micobacteriosis [Tuberculosis y Lepra]. Secretaría de Salud, Subsecretaría de Prevención y Promoción de la Salud, Dirección General de Epidemiología. Septiembre, 2012




2020     |     www.medigraphic.com